| scholarly article | Q13442814 |
| P50 | author | Saber Azami-Aghdash | Q98724205 |
| P2093 | author name string | Aziz Rezapour | |
| Fatemeh Pournaghi-Azar | |||
| Ali Sarabi Asiabar | |||
| Hossein Mashhadi Abdolahi | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Novel therapeutic agents in the treatment of metastatic colorectal cancer | Q26769932 | ||
| Colorectal cancer diagnosis: Pitfalls and opportunities | Q26774105 | ||
| The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer [...] | Q26851531 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
| Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany | Q28539886 | ||
| Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews | Q29547775 | ||
| Efficiency of Health Care Production in Low-Resource Settings: A Monte-Carlo Simulation to Compare the Performance of Data Envelopment Analysis, Stochastic Distance Functions, and an Ensemble Model | Q31040027 | ||
| Content analysis: a qualitative data analysis tool in health care | Q33218301 | ||
| Qualitative data analysis: conceptual and practical considerations. | Q33488682 | ||
| An introduction to Markov modelling for economic evaluation | Q33581197 | ||
| Colon cancer treatment costs for Medicare and dually eligible beneficiaries. | Q33704073 | ||
| Is the societal perspective in cost-effectiveness analysis useful for decision makers? | Q33730677 | ||
| Qualitative data analysis: the framework approach | Q33820025 | ||
| Qualitative data analysis | Q34106559 | ||
| Cost-effectiveness of computed tomography colonography in colorectal cancer screening: a systematic review | Q34420202 | ||
| Meta-analysis in medical research. | Q34627273 | ||
| Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force | Q34740698 | ||
| Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies | Q34992075 | ||
| Generalised cost-effectiveness analysis: an aid to decision making in health | Q35584501 | ||
| Height as an independent anthropomorphic risk factor for colorectal cancer | Q35680126 | ||
| Cost-effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market. | Q35750509 | ||
| Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations | Q40991247 | ||
| Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League | Q41066867 | ||
| Does it matter? Discounting and its role in the cost-effectiveness of preventative interventions. The case of HPV vaccination | Q41361060 | ||
| Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study | Q41595425 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement | Q42035537 | ||
| Colorectal Cancer Screening by Colonoscopy, CT-Colonography, or Fecal Immunochemical Test | Q45128207 | ||
| Cost Effectiveness Of Cetuximab In First Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer In The Uk: A Summary Of Economic Analyses Submitted To The National Institute For Health And Care Excellence (Nice). | Q47972566 | ||
| Identifying Risk Categories in Colorectal Cancer Screening: Promise and Challenges | Q48062653 | ||
| Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah | Q48305904 | ||
| Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis. | Q51493919 | ||
| Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine | Q57345444 | ||
| Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluation of the cost-effectiveness of coronary stenting: a societal perspective | Q77375297 | ||
| Critique of an economic evaluation using the Drummond checklist | Q82274803 | ||
| Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis | Q82860990 | ||
| Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study | Q84791504 | ||
| Obesity is a risk factor for multifocal disease and recurrence after colorectal cancer surgery: a case-control study | Q85664662 | ||
| Counting the cost of end-of-life cancer care | Q87199452 | ||
| Colorectal cancer prevention and intentions to use low-dose aspirin: A survey of 1000 U.S. adults aged 40-65 | Q87326335 | ||
| Updated Canadian colorectal cancer screening guidelines | Q87384639 | ||
| Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? | Q35887504 | ||
| Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis. | Q36152268 | ||
| Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer | Q36443643 | ||
| Age Over 80 is a Possible Risk Factor for Postoperative Morbidity After a Laparoscopic Resection of Colorectal Cancer | Q36495627 | ||
| A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery | Q36527719 | ||
| Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party | Q36599584 | ||
| Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation | Q36644120 | ||
| Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening | Q36649669 | ||
| Cost considerations in the treatment of colorectal cancer | Q36870003 | ||
| The cost of cancer: a retrospective analysis of the financial impact of cancer on young adults | Q36895079 | ||
| Systematic review and meta-analysis: when one study is just not enough | Q37051994 | ||
| Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. | Q37077193 | ||
| Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered | Q37097503 | ||
| A cost analysis of a cancer genetic service model in the UK | Q37124110 | ||
| Epidemiology and management options for colorectal cancer in children | Q37153707 | ||
| Epidemiology and molecular genetics of colorectal cancer in iran: a review | Q37403426 | ||
| Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness : a systematic review | Q38075848 | ||
| Systematic review and quality assessment of cost-effectiveness analysis of pharmaceutical therapies for advanced colorectal cancer | Q38095230 | ||
| Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature | Q38095383 | ||
| An international review of the main cost-effectiveness drivers of virtual colonography versus conventional colonoscopy for colorectal cancer screening: is the tide changing due to adherence? | Q38128453 | ||
| A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer | Q38134928 | ||
| KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis. | Q38260157 | ||
| Global health care of the critically ill in low-resource settings. | Q38403604 | ||
| A framework for evaluating the cost-effectiveness of patient decision aids: A case study using colorectal cancer screening | Q38483811 | ||
| Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review | Q38542962 | ||
| Epidemiology and Results of Treatment of Colorectal Cancer in Poland | Q38713586 | ||
| Aspirin and colorectal cancer: the promise of precision chemoprevention. | Q38730064 | ||
| Clinical pharmacokinetics and pharmacodynamics of ramucirumab in the treatment of colorectal cancer | Q38741222 | ||
| Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis | Q38753052 | ||
| Discounting, preferences, and paternalism in cost-effectiveness analysis | Q39708569 | ||
| Colonoscopy and chromoscopy in hereditary colorectal cancer syndromes | Q39985585 | ||
| The cost-effectiveness of training US primary care physicians to conduct colorectal cancer screening in family medicine residency programs. | Q40001071 | ||
| Cancer care cost trends in the United States: 1998 to 2012. | Q40101403 | ||
| Price, value, and the cost of cancer drugs | Q40116138 | ||
| Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion | Q40363855 | ||
| Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy | Q40397449 | ||
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| systematic review | Q1504425 | ||
| colorectal cancer screening | Q19391980 | ||
| P304 | page(s) | 57-67 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Asia-Pacific journal of oncology nursing | Q27727058 |
| P1476 | title | Cost-effectiveness of Colorectal Cancer Screening and Treatment Methods: Mapping of Systematic Reviews | |
| P478 | volume | 5 |
| Q57074537 | Identification of the predictive genes for the response of colorectal cancer patients to FOLFOX therapy | cites work | P2860 |
Search more.